<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Krasemann S</submitter><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Fraunhofer-Gesellschaft</funding><funding>BMBF Berlin</funding><funding>icare</funding><pagination>307-320</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8772030</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(2)</volume><pubmed_abstract>Neurological complications are common in COVID-19. Although SARS-CoV-2 has been detected in patients' brain tissues, its entry routes and resulting consequences are not well understood. Here, we show a pronounced upregulation of interferon signaling pathways of the neurovascular unit in fatal COVID-19. By investigating the susceptibility of human induced pluripotent stem cell (hiPSC)-derived brain capillary endothelial-like cells (BCECs) to SARS-CoV-2 infection, we found that BCECs were infected and recapitulated transcriptional changes detected in vivo. While BCECs were not compromised in their paracellular tightness, we found SARS-CoV-2 in the basolateral compartment in transwell assays after apical infection, suggesting active replication and transcellular transport of virus across the </pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.</pubmed_title><pmcid>PMC8772030</pmcid><funding_grant_id>840260</funding_grant_id><funding_grant_id>FR1720/18-1</funding_grant_id><funding_grant_id>01EK1608B</funding_grant_id><funding_grant_id>602015</funding_grant_id><funding_grant_id>GL589/10-1</funding_grant_id><funding_grant_id>01EK1608A</funding_grant_id><funding_grant_id>01KX2021</funding_grant_id><pubmed_authors>Cubukova A</pubmed_authors><pubmed_authors>Zaliani A</pubmed_authors><pubmed_authors>Franzenburg S</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Moese S</pubmed_authors><pubmed_authors>Matschke J</pubmed_authors><pubmed_authors>Franke A</pubmed_authors><pubmed_authors>Claussen C</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Littau JL</pubmed_authors><pubmed_authors>Ton K</pubmed_authors><pubmed_authors>Sepulveda-Falla D</pubmed_authors><pubmed_authors>Gribbon P</pubmed_authors><pubmed_authors>Gerhartl A</pubmed_authors><pubmed_authors>Thies E</pubmed_authors><pubmed_authors>Glatzel M</pubmed_authors><pubmed_authors>Ricklefs F</pubmed_authors><pubmed_authors>Pless O</pubmed_authors><pubmed_authors>Bodem J</pubmed_authors><pubmed_authors>Friese MA</pubmed_authors><pubmed_authors>Brachner A</pubmed_authors><pubmed_authors>Haferkamp U</pubmed_authors><pubmed_authors>Muller FJ</pubmed_authors><pubmed_authors>Hartmann K</pubmed_authors><pubmed_authors>Neuhaus W</pubmed_authors><pubmed_authors>Kannt A</pubmed_authors><pubmed_authors>Geisslinger G</pubmed_authors><pubmed_authors>Geiger N</pubmed_authors><pubmed_authors>Pfefferle S</pubmed_authors><pubmed_authors>Fitzek A</pubmed_authors><pubmed_authors>Woo MS</pubmed_authors><pubmed_authors>Heinrich F</pubmed_authors><pubmed_authors>Appelt-Menzel A</pubmed_authors><pubmed_authors>Konig EM</pubmed_authors><pubmed_authors>Leu J</pubmed_authors><pubmed_authors>Krasemann S</pubmed_authors><pubmed_authors>Barenberg J</pubmed_authors><pubmed_authors>Sperhake J</pubmed_authors><pubmed_authors>Ondruschka B</pubmed_authors><pubmed_authors>Sauvigny T</pubmed_authors><pubmed_authors>Schweizer M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.</name><description>Neurological complications are common in COVID-19. Although SARS-CoV-2 has been detected in patients' brain tissues, its entry routes and resulting consequences are not well understood. Here, we show a pronounced upregulation of interferon signaling pathways of the neurovascular unit in fatal COVID-19. By investigating the susceptibility of human induced pluripotent stem cell (hiPSC)-derived brain capillary endothelial-like cells (BCECs) to SARS-CoV-2 infection, we found that BCECs were infected and recapitulated transcriptional changes detected in vivo. While BCECs were not compromised in their paracellular tightness, we found SARS-CoV-2 in the basolateral compartment in transwell assays after apical infection, suggesting active replication and transcellular transport of virus across the </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-05-09T20:36:16.88Z</modification><creation>2022-02-11T16:02:44.029Z</creation></dates><accession>S-EPMC8772030</accession><cross_references><pubmed>35063125</pubmed><doi>10.1016/j.stemcr.2021.12.011</doi></cross_references></HashMap>